This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Data Driven, Hybrid & Full Decentralized Clinical Trials
Mark Your Calendar for Data Driven, Hybrid and Full Decentralized Clinical Trials 2025!
In-Person Event: April 8 - 9, 2025Aloft Boston, Boston, MA
Menu

Gerald E. Finken
CEO at RxE2
Speaker

Profile

Gerald is a licensed pharmacist with over 40 years of experience in the biotechnology and pharmaceutical industries. In 1997, he founded CSM, a clinical supplies packaging and labeling company, where he invented On-Demand packaging and labeling, Clinical Trial Research Pharmacist (CTRP®) services, and pioneered Direct-to-Patient services. In 2013, he founded Center Point Clinical Services and subsequently created the innovative Siteless CRO model. In 2020, Gerald launched RxE2 where he now serves as CEO and is bringing the practice of pharmacy to clinical trials.

Linkedin: https://www.linkedin.com/in/gfinken/

Twitter: https://twitter.com/geraldfinken



Agenda Sessions

  • Novel Hybrid Site Models – Innovation to Traditional Methods

    , 12:30pm
    View Session

At this event

Prev
Next
Doug Foster
Partner
Advanced Data Sciences

See Gerald at Data Driven, Hybrid & Full Decentralized Clinical Trials